Plain Language Study Results Summaries
What Are Plain Language Study Results Summaries?
Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.
Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.
Filter Results
Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.
Category & Conditions: Rare Diseases
Study Phase : 2
Medicine: recifercept
Language: Dutch
ViewDownloadPrintCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: recifercept
Language: English
ViewDownloadPrintCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: recifercept
Language: French
ViewDownloadPrintCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: recifercept
Language: Spanish
ViewDownloadPrintCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: recifercept
Language: English
ViewDownloadPrintCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrintCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrintCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrintCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrintCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrintCategory & Conditions: Gastrointestinal Disorders
Study Phase : 1
Medicine: ritlecitinib (PF-06651600)
Language: English
ViewDownloadPrint